5
Clinical Trials associated with Mitiglinide Calcium Hydrate/Voglibose / CompletedNot ApplicableIIT Clinical study on of combination therapy with a DPP-4 inhibitor and a mitiglinide/voglibose fixed-dose combination (the combination) on glycemic/metabolic responses after meals in patients with type 2 diabetic mellitus (T2DM) - Clinical study on combination therapy with a DPP-4 inhibitor and the combination in T2DM patients
Start Date18 Nov 2013 |
Sponsor / Collaborator- |
/ CompletedNot ApplicableIIT Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes. - Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes.
Start Date23 Jul 2013 |
Sponsor / Collaborator- |
/ CompletedNot ApplicableIIT Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function - EGEF trial
Start Date01 Apr 2012 |
Sponsor / Collaborator- |
100 Clinical Results associated with Mitiglinide Calcium Hydrate/Voglibose
100 Translational Medicine associated with Mitiglinide Calcium Hydrate/Voglibose
100 Patents (Medical) associated with Mitiglinide Calcium Hydrate/Voglibose
100 Deals associated with Mitiglinide Calcium Hydrate/Voglibose